Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.4.4 (
kinesin
)
5,033
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
During bidirectional transport, individual cargoes move continuously back and forth along microtubule tracks, yet the cargo population overall displays directed net transport. How such transport is controlled temporally is not well understood. We analyzed this issue for bidirectionally moving lipid droplets in Drosophila embryos, a system in which net transport direction is developmentally controlled. By quantifying how the droplet distribution changes as embryos develop, we characterize temporal transitions in net droplet transport and identify the crucial contribution of the previously identified, but poorly characterized, transacting regulator
Halo
. In particular, we find that
Halo
is transiently expressed; rising and falling
Halo
levels control the switches in global distribution. Rising
Halo
levels have to pass a threshold before net plus-end transport is initiated. This threshold level depends on the amount of the motor
kinesin
-1: the more
kinesin
-1 is present, the more
Halo
is needed before net plus-end transport commences. Because
Halo
and
kinesin
-1 are present in common protein complexes, we propose that
Halo
acts as a rate-limiting co-factor of
kinesin
-1.
...
PMID:Temporal control of bidirectional lipid-droplet motion in Drosophila depends on the ratio of kinesin-1 and its co-factor Halo. 2690 17